August 1, 2013 | Foundation Medicine filed plans this week to raise $86.25 million in an IPO, and the Boston Globe posits it could be aiming too low. Another recent Third Rock Ventures biotech raised more than 20% more than it expected last week and Foundation Medicine's technology is strong. For background see Laying the Foundation for Next-Gen Cancer Diagnostics and Foundation Medicine Partners with Memorial Sloan-Kettering. Boston Globe